Editas Medicine Inc (NASDAQ:EDIT)

41.87
Delayed Data
As of Jul 30
 -0.03 / -0.07%
Today’s Change
27.01
Today|||52-Week Range
99.95
-40.28%
Year-to-Date

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Editas Medicine Inc have a median target of 40.00, with a high estimate of 81.00 and a low estimate of 20.00. The median estimate represents a -4.47% decrease from the last price of 41.87.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Hold stock in Editas Medicine Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.82
Sales
$6.0M
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.24%
 
 
 
 
 
 
Growthannually -75.65%
 
 
 
 
 
 

Sales

Growthquarterly -7.25%
 
 
 
 
 
 
Growthannually -73.22%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.